153 related articles for article (PubMed ID: 16632824)
21. Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic.
Cooper DM; Hoffman W; Wheat N; Lee HY
Comp Med; 2005 Aug; 55(4):344-53. PubMed ID: 16158910
[TBL] [Abstract][Full Text] [Related]
22. Dose-related antinociceptive effects of intravenous buprenorphine in cats.
Steagall PV; Mantovani FB; Taylor PM; Dixon MJ; Luna SP
Vet J; 2009 Nov; 182(2):203-9. PubMed ID: 18691917
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
Cichewicz DL; Welch SP; Smith FL
Eur J Pharmacol; 2005 Nov; 525(1-3):74-82. PubMed ID: 16288738
[TBL] [Abstract][Full Text] [Related]
24. The antinociceptive and anti-inflammatory effects of five depot formulations of ketorolac propyl ester in rats.
Wang LK; Wang PJ; Hou CH; Chu CC; Tzeng JI; Shieh JP; Wang JJ
Acta Anaesthesiol Taiwan; 2005 Jun; 43(2):85-92. PubMed ID: 16060403
[TBL] [Abstract][Full Text] [Related]
25. A preclinical comparison between different opioids: antinociceptive versus adverse effects.
Meert TF; Vermeirsch HA
Pharmacol Biochem Behav; 2005 Feb; 80(2):309-26. PubMed ID: 15680184
[TBL] [Abstract][Full Text] [Related]
26. Influence of preferred foodstuffs on the antinociceptive effects of orally administered buprenorphine in laboratory rats.
Leach MC; Forrester AR; Flecknell PA
Lab Anim; 2010 Jan; 44(1):54-8. PubMed ID: 19858164
[TBL] [Abstract][Full Text] [Related]
27. An esterification method for synthesizing prodrugs of buprenorphine.
Chin LS; Huang KL; Liu KS; Chu CC; Tzeng JI; Ho ST; Wang JJ
Acta Anaesthesiol Taiwan; 2005 Dec; 43(4):223-9. PubMed ID: 16450597
[TBL] [Abstract][Full Text] [Related]
28. Thermoregulatory, motor, behavioural, and nociceptive responses of rats to 3 long-acting neuroleptics.
Fick LG; Fuller A; Mitchell D
Can J Physiol Pharmacol; 2005 Jun; 83(6):517-27. PubMed ID: 16049552
[TBL] [Abstract][Full Text] [Related]
29. The antinociceptive effect of a long-acting nalbuphine preparation in rabbits.
Ho ST; Wang JJ; Hu OY; Tzeng JI; Liu KS; Chen YW
Acta Anaesthesiol Sin; 2003 Sep; 41(3):99-103. PubMed ID: 14601195
[TBL] [Abstract][Full Text] [Related]
30. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Likar R; Kayser H; Sittl R
Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
[TBL] [Abstract][Full Text] [Related]
31. Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs.
Pieper K; Schuster T; Levionnois O; Matis U; Bergadano A
Vet J; 2011 Mar; 187(3):335-41. PubMed ID: 20206560
[TBL] [Abstract][Full Text] [Related]
32. Lack of analgesic efficacy in female rats of the commonly recommended oral dose of buprenorphine.
Thompson AC; DiPirro JM; Sylvester AR; Martin LB; Kristal MB
J Am Assoc Lab Anim Sci; 2006 Nov; 45(6):13-6. PubMed ID: 17089985
[TBL] [Abstract][Full Text] [Related]
33. Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats.
Steagall PV; Carnicelli P; Taylor PM; Luna SP; Dixon M; Ferreira TH
J Vet Pharmacol Ther; 2006 Dec; 29(6):531-7. PubMed ID: 17083457
[TBL] [Abstract][Full Text] [Related]
34. Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations.
Thompson AC; Kristal MB; Sallaj A; Acheson A; Martin LB; Martin T
Comp Med; 2004 Jun; 54(3):293-300. PubMed ID: 15253276
[TBL] [Abstract][Full Text] [Related]
35. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
36. Differences in response to anaesthetics and analgesics between inbred rat strains.
Avsaroglu H; van der Sar AS; van Lith HA; van Zutphen LF; Hellebrekers LJ
Lab Anim; 2007 Jul; 41(3):337-44. PubMed ID: 17640461
[TBL] [Abstract][Full Text] [Related]
37. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
38. Analgesic efficacy of orally administered buprenorphine in rats.
Martin LB; Thompson AC; Martin T; Kristal MB
Comp Med; 2001 Feb; 51(1):43-8. PubMed ID: 11926301
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology of buprenorphine in healthy, lactating goats.
Ingvast-Larsson C; Svartberg K; Hydbring-Sandberg E; Bondesson U; Olsson K
J Vet Pharmacol Ther; 2007 Jun; 30(3):249-56. PubMed ID: 17472657
[TBL] [Abstract][Full Text] [Related]
40. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
